Pemvidutide achieves 15.6% weight loss at 48 weeks
Topline results from the MOMENTUM Phase 2 obesity trial of pemvidutide has shown at week 48, subjects receiving pemvidutide achieved mean...
top of page
Browse by category
Search
Browse by tag
bottom of page